Research and Development

Showing 15 posts of 9600 posts found.

Bristol-Myers Squibb

BMS establishes cancer vaccine network

June 1, 2012 Research and Development, Sales and Marketing

Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …

ROCK medical communications appoints two new account managers

June 1, 2012 Medical Communications, Research and Development, Sales and Marketing ROCK, medical communications, pharma appointment

ROCK medical communications has appointed two new team members: Suzanne Smith and Nicola Wood. Suzanne joins from Chameleon Communications, where …

Boehringer appoints new executive director of Consumer Healthcare Marketing

May 31, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division.  In …

Pharma relieved as Senate backs FDA fees

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing FDA, PDUFA, PhRMA, US

The US Senate has approved a law that will continue to allow pharma firms to help fund the FDA.  The …

Photo story: GSK’s 2012 legacy

May 30, 2012 Research and Development Andrew Witty, GSK, Olympics 2012

Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …

GSK starts combination trial for melanoma

May 30, 2012 Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma

GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs.  The firm will combine dabrafenib, its …

UK Prix Galien shortlist announced

May 30, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Bayer, Janssen, Xarelto, awards, prix galien

The UK award for the most innovative new drug has been moved a step closer with the release of a …
brian_jolly_at_onyx_scientific_

Onyx appoints Brian Jolly to commercial team

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing

Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012 Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …

Lundbeck’s Alzheimer’s drug shows promise

May 29, 2012 Research and Development, Sales and Marketing Alzheimer's, Lundbeck

Lundbeck’s Alzheimer’s candidate Lu AE58054 has shown signs in a phase II study of helping patients’ mental activity. Sufferers receiving …
Pradaxa image

European OK for Pradaxa, but more details required

May 29, 2012 Research and Development, Sales and Marketing Boehringer, CHMP, EMA, Europe, Pradaxa

The European Medicines Agency says that Boehringher’s Pradaxa can stay on the market, but will need more safety information.  The …

Life bolsters its client services team with two additions

May 28, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Life Healthcare Communications has developed its client services team with two new appointments to further support the needs of its …

Pfizer appoints two senior roles

May 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, Read

Pfizer has named Olivier Brandicourt as president and general manager of its Emerging Markets and Established Products Business Units, and …

Boehringer’s COPD drug passes hurdle

May 23, 2012 Research and Development, Sales and Marketing Boehringer, COPD, Daxas, Relovair, Spiriva, olodaterol

Boehringer Ingelheim’s once-daily bronchodilator olodaterol has improved lung function versus placebo in a Phase II trial.  The manufacturer wants the …
Doctor laptop image

Medical education: pharma’s evolving relationship with healthcare professionals

May 23, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, InPharm, MEP, medical education

There are at least two perspectives of what ‘Medical Education’ means, and certainly many definitions.For doctors and other healthcare professionals, …
The Gateway to Local Adoption Series

Latest content